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Abstract
Metabolic disorders due to over-nutrition are a major global health problem, often associ-
ated with obesity and related morbidities. Obesity is peculiar to humans, as it is associated
with lifestyle and diet, and so difficult to reproduce in animal models. Here we describe a
model of human central adiposity based on a 3-tissue system consisting of a series of inter-
connected fluidic modules. Given the causal link between obesity and systemic inflamma-
tion, we focused primarily on pro-inflammatory markers, examining the similarities and
differences between the 3-tissue model and evidence from human studies in the literature.
When challenged with high levels of adiposity, the in-vitro system manifests cardiovascular
stress through expression of E-selectin and von Willebrand factor as well as systemic
inflammation (expressing IL-6 and MCP-1) as observed in humans. Interestingly, most of
the responses are dependent on the synergic interaction between adiposity and the pres-
ence of multiple tissue types. The set-up has the potential to reduce animal experiments in
obesity research and may help unravel specific cellular mechanisms which underlie tissue
response to nutritional overload.
Introduction
Overweight and obesity are major risk factors for a number of chronic diseases, including dia-
betes [1], cardiovascular diseases and cancer [2]. Since the turn of the century, the number of
obese adults has increased to over 300 million. Obese individuals often have excess central vis-
ceral adiposity, a condition that contributes to a chronic increase in circulating free fatty acids
and metabolites, such as glycerol and triglycerides. These metabolites in turn activate various
signaling cascades that interfere with insulin signaling and β-cell function, further contributing
to gluco/lipotoxicity [3].
A great deal of research has been dedicated to delineate the etiopathogenic mechanisms of
obesity and diabetes using animal models. The most widely employed models of obesity are
rodents, either mutant or genetically engineered mice or rats in which adiposity is induced by
prolonged feeding on high fat diets [4,5]. As succinctly put by Wang et al, “despite the extensive
use of these rodent models, many mechanistic details of human metabolism remain poorly
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understood and treatment options for humans are limited and largely unsatisfactory” [6]. Indeed,
we now know much about the details of rodent metabolism, but still lack a detailed under-
standing of the mechanisms underlying human glucose homeostasis and response to chronic
over-nutrition as well as human obesity related comorbidities and responses to interventions
[7].
Besides the evident differences between human and rodent lifespan, diet, and basic biology,
animal models are not amenable to dissociation of metabolite dynamics in different tissues
and organs. As a consequence, identifying the contribution of individual tissues or organs to
nutrient balance or destabilization is a formidable task. Some attempts have been made to
model human obesity using in-vitro techniques, most of these deal with adipose cell or tissue
cultures, derived from cell lines or isolated from donors [8,9]. In-vitro research has contrib-
uted significantly to our understanding of alterations in signaling at the membrane or cyto-
plasmic level in single cells [10,11]. Thus, although there is clearly a network of signaling
between different tissues which contributes to maintain energy homeostasis in the human
body, much of our understanding of signal transduction is limited to a very small space and
time window. The question of how metabolic signals are propagated to and translated by
remote tissues and organs, and how the internal milieu is modulated by them has not yet been
addressed, with very little research carried out on higher level models of endogenous metabo-
lism containing different cell or tissue types.
Several microfluidic systems involving multiple tissues are now emerging, while most are
focused on systemic toxicity [12,13]. Xiao et al recently demonstrated that reproductive tract
tissues can be cultured together under flow to produce a semblance of the human menstrual
cycle hormonal profile [14]. However, as far as nutrient metabolism is concerned, very little
work has been done on models involving the interactions between different cells or tissues
linked in the body through the vascular network. In fact, the metabolic circuitry involves all
organs and tissues, most of them as end receivers of energetic substrates, which in normal rest-
ing conditions, are generally glucose and some free fatty acids (FFAs) [15]. Some organs and
tissues play more important roles such as the engineering equivalents of processing, sorting,
storage and control [16]. Recapitulating systemic metabolism is a challenging task and requires
a methodical reverse engineering approach, breaking down the circuitry to its most basic ele-
ments and reconstructing the metabolic network in-vitro. By increasing the number of inter-
actions and variables step-wise in a properly scaled model, nutrient dynamics between organs
and their contribution to the whole body metabolic profile can be systematically investigated
[17].
Using this approach we previously reported a modular in-vitro system for the study of glu-
cose and lipid dynamics in a model of central metabolism [18,19]. The system consists of inter-
connected bioreactor chambers linked together by the flow of a common medium, containing
respectively human adipose tissue, human endothelial cells and a human hepatocyte cell line.
Cell ratios were scaled proportionally to represent adipose tissue, vascular tissue and liver in
the abdomen [20,21]. This paper builds on a series of studies in which we demonstrated that
fluid flow reduces glucose uptake and increases lactate availability in all cells, particularly hepa-
tocytes and endothelial cells [22]. Hepatocytes are the master regulators in the 3 tissue fluidic
connected culture (herein referred to as 3-way), as their introduction to the 2 tissue (2-way)
endothelial cell-adipose tissue circuit markedly reduced changes in metabolite concentrations
with respect to fresh media levels [18]. Following these initial investigations, the 3-way system
was challenged with high glucose concentrations with and without insulin to simulate type I
and type 2 diabetes respectively. The results demonstrated that the system’s metabolic and
inflammatory profile changes dramatically in the presence of high concentrations of glucose,
and that these changes are modulated by the presence of insulin, highlighting its potential to
In-vitro model of central obesity
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recapitulate some of the characteristics of human metabolism in the presence of nutritional
overload [19]. Here, the 3-way model was refined to include 3D porous collagen scaffolds, a
high shear vascular compartment and different levels of human adiposity. Maintaining physio-
logically scaled cell ratios for endothelial cells and hepatocytes, we added increasing adipose
cell amounts to represent normo-weight with 12% adipose tissue (12%AT), overweight (25%
AT) and obese (35%AT) conditions respectively. The aim of the study was to challenge the in-
vitro system with increasing levels of adiposity to determine the extent to which the 3-tissue
fluidic system reflects salient features of obesity-related vascular and systemic stress observed
in humans.
Material and methods
Cells
As in our previous studies, cell proportions in the 3-way set up represented the hepatocyte:adi-
pocyte:endothelial ratio in the visceral region, i.e. 12%AT 10:2:1 for normo-weight; 25%AT
10:4:1 for overweight; 35%AT 10:6:1 for obese [18].
Human Umbilical Vein Endothelial Cells (HUVEC, passage 4 to 6) were from Promocell.
They were cultured in ECGM (Endothelial Cell Growth Medium, Promocell) with 10% di FBS
(Fetal Bovine Serum), 0.1 ng/mL EGF (Epidermal Growth Factor), 1.0 ng/mL BFGF (Basic
Fibroblast Growth Factor), 90 μg/mL heparin, 1.0 μg/mL hydrocortisone, and pen-strep. This
cocktail is henceforth referred to as the common media. The cells (38,000) were pipetted into
the μ-Slides which had been prepared by coating with 200 μL of 1% gelatin followed by 24 h
pre-incubation in a 37˚C oven.
The hepatocyte cell line HepG2 was from ATCC (American Type Culture Collection).
These cells maintain the principal endogenous functions of human hepatocytes and respond
to glucose-6-phosphate, conserving their capacity to synthesize glycogen [23]. Hepatocytes
were passaged in EMEM with 1g/L glucose, 5% FBS and pen-strep. 150,000 cells were carefully
pipetted into the center of porous collagen scaffolds (porosity 98%, pore size 200 μm, elastic
modulus 1.2 kPa) placed in 48-well plates. The cells were incubated in the common media 48
hours before starting the connected culture experiments. After this time the cells proliferate to
about 400,000–450,000, as ascertained by cytometry, and are ready for the 3-way experiments.
Visceral adipose tissue was obtained from n = 9 donors undergoing liver resection for
metastatic/benign liver lesions with no underlying chronic liver disease or diabetic complica-
tions and BMI (body mass index) ranging from 20 to 25. All patients provided their written
informed consent to participate in the study, which was approved by the Local Ethical Com-
mittee (Study n. 3059 approved on 21/07/2011 by the Azienda Ospedaliera Università Pisana).
The study was carried out in accordance with guidelines established by the Local Ethical Com-
mittee. The tissue was cleaned of visible blood vessels and divided into weighed portions repre-
senting i) normo-weight, 56 mg, ii) overweight, 112 mg, and iii) obese, 168 mg. The weighed
samples were placed in wells and partially digested in collagenase (Sigma) for 10 min. They
were then rinsed in EMEM with 20% FBS and pen-strep before inserting in the bioreactors.
Using this procedure, we obtain a yield of about 1500 adipocytes/mg [22].
Bioreactors
The bioreactors were LB1 and LB2 (IVTech srl, IT) and μ-Slide (Ibidi, DE). LB1 is a 24-well
sized transparent milli-scaled chamber for fluidic culture of scaffolds and membranes under
low shear stress, while LB2 has 2 flow inputs and outputs (Fig 1). The 400 μm channel height
of the μ-Slide is designed for simulating the high shear vascular environment.
In-vitro model of central obesity
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A LB2 chamber was used for adipose tissue employing a cross-flow configuration for non-
adherent cultures as recommended by the manufacturer. The tissue was contained in the
chamber by piece of sterile nylon mesh. Hepatocytes seeded on collagen sponges were placed
in an LB1 chamber while the μ-Slide was used for endothelial cells. In the 1-way experiments,
each cell type was placed in the flow circuit singly. The 2-way experiments were conducted by
connecting an LB2 chamber with adipose tissue to a μ-Slide with HUVEC. Finally, in the
3-way tests, one LB1 chamber with hepatocytes was added to the 2-way circuit. In all experi-
ments (i.e. 1-way, 2-way and 3-way, see below), the total circuit volume was 14 mL, and the
common medium was complete ECGM, which conserves the vitality of HepG2 and adipose
tissue with respect to their standard media [22].
After seeding, the chambers were assembled using Luer connectors to form a closed loop
circuit containing a peristaltic pump (Ismatech, CH) and a mixing chamber (IVTech srl, IT) as
shown in Fig 1. The flow rate was 250 μL/min which gives a wall shear stress of 5 μPa in LB1
[24], and 0.35 Pa in the μ-Slide and guarantees adequate nutrient transport to cells in 3D con-
structs [25].
1, 2 and 3-way cultures
The metabolic and inflammatory response of normo-weight, overweight, and obese (respec-
tively 12%AT, 25%AT and 35%AT) amounts of adipose tissue was investigated in 1-, 2- and
Fig 1. a) Basic components of the 3-way fluidic system: the LB1 chamber, the Ibidi laminar flow chamber, and the LB2 chamber; b) the fluidic set up with a
peristaltic pump, mixing chamber and hepatic (LB1), endothelial (Ibidi) and adipose tissue (LB2) chambers; c) HepG2 cells stained with DAPI (blue) and actin-
phalloidin (red) seeded on porous collagen scaffolds (green autofluoresence). Scale bar 50 μm; d) endothelial cells stained with calcein. Scale bar 50 μm; e)
adipocytes stained with oil-red. Scale bar 50 μm.
https://doi.org/10.1371/journal.pone.0192824.g001
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3-way cultures using transparent bioreactors linked in series (Fig 1a and 1b). Firstly, using the
same volume of ECGM medium in all tests, the fat compartment was characterised to obtain
internal controls to account for variations due only to the mass of adipose tissue in a 1-way AT
system. One-way responses of hepatic and endothelial cultures in the fluidic system were also
assessed. Then an intermediate 2-way circuit with endothelial cells and adipose tissue was
established, followed by a 3-way circuit with hepatocytes seeded on porous 3-dimensional col-
lagen scaffolds, endothelial cells and adipose tissue. Different percentages of adipose tissue
were added to the 2- and 3-way system in order to mimic different degrees of adiposity,
keeping the hepatic and endothelial compartments constant. The metabolic profile and pro-
inflammatory responses were evaluated to clarify the role of adiposity and the contribution of
the different cell types in modulating media metabolite and stress-marker levels. Glucose,
human albumin, urea and lactate levels were also monitored over time. As illustrated in Fig 1c
and 1e, the cells were vital and adipocyte dimensions were conserved over the 24 hours of the
experiments.
Cell viability
The viability of all three cell types in the connected cultures was measured and evaluated
through the lactate dehydrogenase (LDH) assay using the method described by Decker and
Lohmann-Matthes [26].
Biomolecule analyses
In order to assess the cell functions and viability, 200 μL of media were withdrawn from the
mixing chamber at fixed intervals (0, 4, and 24 h). Biochemical assays were performed to mea-
sure the change over time in the metabolite and pro-inflammatory marker levels in the media.
Free Fatty Acids (FFAs) and triglycerides were measured by a colorimetric enzyme assays
(respectively NEFA C test-Wako Chemicals GmbH, Germany and Hagen Diagnostica SRL,
S. Giovanni V.no (AR), ITALY). Glycerol was determined by a modified Lloyd assay using an
automated spectrophotometer Cobas Fara II (Roche) [27]. IL-6, (eBioscience Dx Diagnostic,
Vienna, Austria), E-Selectin, (Boster Biological Technology, LDT, Tema Ricerca, Bologna,
Italy), MCP-1 (Life Technologies Italia, Monza-MI, Italy, albumin (Bethyl Laboratories, Mont-
gomery, TX, USA), were determined using ELISA. Other assays and their results are reported
in the Supporting Information, S1 File.
At the end of the experiments the cells were fixed and stained with DAPI and phallodin or
anti-vWF (all from Thermo Fischer, Italy) and observed with a confocal (Nikon A1, IT) or
fluorescent microscope (Olympus X81, IT). Adipose tissue was stained with oil-red stain. The
intensity of vWF staining was quantified by image processing as described in the Supporting
Information, S1 File.
Data analysis
Results are reported as the mean ± standard deviation, unless otherwise noted. The statistical
differences in metabolite and cytokine concentrations (with respect to fresh media) between
the three levels of adiposity in 1-, 2- and 3-way connected cultures was analysed using two-way
ANOVA followed by Tukey’s Multiple Comparison Test in order to evaluate both the effect of
varying the adiposity for a given model complexity (i.e. 1, 2 or 3-way) and that of changing
model complexity for a given level of adiposity (i.e. 12, 25 or 35%AT). Since human albumin
is only secreted by the hepatocytes (as the medium contains bovine albumin), its production
was evaluated only for the most complex 3-way hepatocyte-containing circuit: the effect of adi-
posity in the 3-way system was tested with 1-way ANOVA followed by Tukey’s Multiple
In-vitro model of central obesity
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Comparison Test, and results compared to the basal albumin production of the hepatocyte
monoculture. Similarly, statistical significance between selectin and vWF levels for the differ-
ent 3-way conditions and the single 1-way controls was determined with one-way ANOVA.
Post-hoc multiple comparisons between different groups of data were carried out using the
Tukey’s test. Statistical analysis was implemented in Graphpad Prism 6.0. Differences were
considered significant at p< 0.05. At least 3 different experiments were conducted for each
condition, using adipose tissue from a total of 9 different donors. Since the tissue was obtained
from donors with no underlying chronic metabolic disease or obesity, we expect no significant
variability in adipose cell volume or function. Further donor-to-donor variability was mini-
mised by ensuring that each experimental triplicate contained adipose tissue randomly
selected from 3 out of the 9 donors. Details on the image processing methods are reported in
the Supporting Information, S1 File.
Results
Lipids and albumin
The effect of both adiposity (i.e. 12, 25 and 35%AT) and model complexity (i.e. 1-, 2- and
3-way) on the production of triglycerides (TRG), glycerol (GLY), FFAs and albumin (HA)
after 24 h of culture was investigated in order to determine whether and how lipids and lipid-
related metabolite levels in the system are modulated by the amount of adipose tissue consid-
ered in the model and/or by cross-talk between multiple tissues. Significant interaction
between adiposity and the level of cross-talk was found for TRG production (p = 0.0039),
meaning that the effect of the first factor is dependent on the level of the second one, and
vice-versa. Overall more triglycerides were released from cells in the culture medium over 24
h in the 3-way cultures (Fig 2a). In particular, 3-way TRG production was higher than 2-way
at 12% adiposity (p = 0.0138), while it was higher than both 1- and 2- way at 25% adiposity
(p<0.0001). However, in neither case did the concentrations correlate with the percentage of
adipose tissue in the system. Similarly, the two variability factors investigated (i.e. adiposity
and system complexity) also interact significantly for glycerol production (p<0.0001). Glyc-
erol concentrations were increased over 24 hours in all the 3-way circuits with respect to the
1-way adiposity controls, particularly in the 25%AT system where the levels were more than
doubled with respect to all the other conditions (2-way ANOVA multiple comparison analy-
sis p<0.037, Fig 2b). Significant variable interaction was also found for FFAs (p<0.0001). In
particular, their production significantly decreases with increasing adiposity in the 1-way AT
cultures (p<0.0003). On the other hand, although we observed a net release of FFAs in the
3-way media over 24 hours (Fig 2c), the levels were very similar independent of the percent-
age of adipose tissue added to the system. In fact, the 2-way ANOVA interaction analysis
shows that FFA levels depend on adiposity (p<0.0001), but only in the absence of other cell
types.
Albumin secretion increased with the amount of adipose tissue in the 3-way circuit (Fig
2d), being significantly higher at 35% adiposity with respect to 12% AT (p = 0.0264). Hepato-
cytes seeded on collagen scaffolds in the absence of other cells in connection secreted signifi-
cantly less albumin (3.38±1.28 μg/mL, p = 0.004 with respect to 3-way 12%AT, 1-ANOVA)
over 24 h. As albumin is a carrier of fatty acids, its increased secretion by hepatocytes may be
directly associated with the increase in adiposity and correlated with the levelling of FFA con-
centrations observed in Fig 2c. These data suggest that the 3-tissue cross-talk stabilises media
FFA concentrations, likely through increased triglyceride (Fig 2a) and albumin (Fig 2d) pro-
duction by hepatocytes.
In-vitro model of central obesity
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Glucose, lactate and urea
After 24 h of culture, the effect of both adiposity (i.e. 12, 25 and 35%AT) and model complexity
(i.e. 1-, 2- and 3-way) on media levels of glucose, lactate and urea was investigated in order to
determine whether and how the amount of adipose tissue in the model and/or cross-talk
between multiple tissues affect the production/consumption of the latter molecules. Significant
interactions between adiposity and model complexity were found for glucose (p = 0.0098), lac-
tate (p< 0.0001) and urea (p< 0.0001), meaning that the effect of the first factor is dependent
on the level of the second one, and vice-versa.
In most cases (6 out of 9), glucose consumption was observed, as indicated by the negative
Δglucose values in Fig 3a. Overall, this consumption seemed to increase with both model com-
plexity and adiposity. However, there are some exceptions that complicate data analysis, mak-
ing it difficult to extrapolate clear trends. For instance, i) glucose uptake was observed in
1-way-25%AT model, while the other two 1-way models showed glucose release, and ii) glu-
cose release was observed for 2-way-25%AT model, while the other two 2-way ones showed
glucose uptake: this is reflected in the significant variable interaction for glucose.
An increase in lactate production was generally found with both model complexity and adi-
posity (Fig 3b), with the only exception of 1-way-25%AT one exhibiting lower values than
1-way-12%AT and 35%AT ones (although not significant, likely owing to the high variability
of the other data considered in the global 2-way ANOVA analysis).
A significant increase in urea production was found between 25%AT and 35%AT adiposity
for both 1-way, 2-way and 3-way models (p< 0.0001) (Fig 3c). In 1- and 2-way models, a
Fig 2. Change in metabolite concentrations with respect to fresh media after 24h. a) Triglycerides (TRG); b) Glycerol; c) FFAs; d) Human albumin
(HA). For a), b), and c) the change AT content in 1-, 2- and 3-way cultures was compared within the same group,  = p<0.05. For d) the control is a
1-way hepatocyte culture.  = p<0.05 with respect to the corresponding 1-way control (n = 3 independent experiments for data each point).
https://doi.org/10.1371/journal.pone.0192824.g002
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significant decrease in urea production was observed between 12%AT and 25%AT (p< 0.0001
and p = 0.0039, respectively), while a significant increase between the latter two was found for
3-way models (p = 0.0150), as reflected in the significant interaction between the two factors.
(p = 0.0138), while it was higher than both 1- and 2- way at 25% adiposity (p<0.0001). How-
ever, in neither case did the concentrations correlate with the percentage of adipose tissue in
the system. Additional data on complete 2-way ANOVA analyses, intermediate time-points
and metabolite values for HepG2 and HUVEC are reported in the Supporting Information
(S1 File).
Pro-inflammatory markers
Two systemic pro-inflammatory markers were investigated: Interleukin-6 (IL-6) and Mono-
cyte chemoattractant protein-1 (MCP-1). Our data confirmed that there was a significant
(p<0.001) increase in IL-6 when HUVEC and hepatocytes were connected to 35%AT or 25%
AT, as shown in Fig 4a. The synergic interaction between adiposity and connectivity giving
rise to high levels of this cytokine in the presence of 25 and 35% adipocytes in the 3-way
group was confirmed by the interaction analysis (p<0.0001, 2-way ANOVA) (Fig 4b). MCP-
1 levels were highly correlated with adiposity in both the controls and 3-way condition, an
indication of insignificant variable interaction (p = 0.1637, 2-way ANOVA). In the media of
3- way connections with 25%AT we found a net increase in MCP-1 medium concentrations
with respect to those observed in presence of 12%AT (p = 0.0022) or 35%AT (p = 0.0183), Fig
4b. IL-6 and MCP-1 were close to the detection limit in the 1-way HUVEC and 1-way hepa-
tocyte circuits.
Fig 3. Change in glucose, lactate and urea at 24 h. a) Glucose; b) Lactate; c) Urea. In all cases the change AT content in 1-, 2- and 3-way cultures
was compared within the same group,  = p<0.05.
https://doi.org/10.1371/journal.pone.0192824.g003
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Endothelium specific markers
As obesity related cardiovascular complications are closely associated with endothelial
dysfunction [28], we also focused on two markers of endothelial stress in the 3-way system,
comparing responses with 1-way controls with only HUVEC. E-selectin, is a cell adhesion
molecule expressed only on endothelial cells activated by cytokines and is an early indicator of
endothelial damage. Von-Willebrand Factor (vWF) is produced constitutively in the Weibel-
Palade bodies of the endothelium and is a more tardive marker of endothelial stress with
respect to E-selectin [29,30].
When 12%AT was connected to HUVEC and HepG2 cells, medium E-selectin levels were
stable over 24 hours, with levels similar to those of 1-way HUVEC (Fig 5a). As adiposity in the
system was increased we observed a significant release of E-selectin (p<0.0001 35%AT vs. 12%
AT and the control; p<0.0001 25%AT vs. 12%AT and the control), showing that the presence
of a higher amount of fat can induce endothelial stress (Fig 5a). vWF expression in HUVEC
was measured using immunostaining and image quantification as described in S1 File. A sig-
nificant (over 2-fold, p = 0.0012) increase in vWF fluorescence per cell was observed in going
from HUVEC in the 3-way connection with 12%AT to 35%AT and 25%AT. No difference was
observed between negative controls (HUVEC only) and HUVEC in 3-way with 12%AT. LPS
treated cells were used as positive controls (Fig 5b).
Fig 4. Pro-inflammatory markers at 24h. a) Changes in IL-6 concentration in 1-, 2- and 3-way connected cultures as a function of
adiposity; b) Changes in MCP-1 concentration in 1-2- and 3-way connected cultures as a function of adiposity.  = p<0.05 (n = 3
independent experiments for data each point).
https://doi.org/10.1371/journal.pone.0192824.g004
Fig 5. Endothelial-specific markers at 24h. a) Changes in E-selectin concentration in 3-way connected cultures and
in HUVEC-1-way control.  = p<0.0001 with respect to control; b) Relative vWF fluorescence intensity in 3-way
connected cultures and HUVEC-1-way controls.  = p<0.05 with respect to the corresponding LPS-free 1-way control
(n = 3 independent experiments for data each point).
https://doi.org/10.1371/journal.pone.0192824.g005
In-vitro model of central obesity
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Discussion
Hepatocytes seeded on 3D porous collagen scaffolds, endothelial cells and adipose tissue were
cultured together in a fluidic system. Keeping the hepatic and endothelial compartments con-
stant, the quantity of adipose tissue (AT) was varied to represent central or visceral obesity
(35%AT), overweight (25%AT) and normo-weight (12%AT) respectively. Our aim was to
investigate the interactions among the three tissues as a function of the percentage of adipose
tissue as a first step towards the development of a non-animal model for studying the effects of
obesity in humans. Given the association between adiposity and hyperlipidemia as well as the
causal link between obesity and systemic inflammation [31], we focused primarily on lipid-
related molecules and pro-inflammatory markers, examining the similarities and differences
between the 3-way model and evidence from human studies in the literature.
Obesity is a complex condition which is characterised by an increase in the number of adi-
pocytes as well as the amount of fat stored in the cells [32]. Moreover, obesity is also related to
infiltration of adipose tissue by macrophages [33]. Indeed, adipose tissue consists of a variety
of different cell types: adipocytes, preadipocytes, stromal/vascular cells and macrophages [34].
We used adipose tissue from donors who did not suffer from excess weight or metabolic disor-
ders, in order to minimise variability due to differences in cell volumes or increased endoge-
nous inflammation which may arise in obese, overweight or diabetic samples. Therefore, in
our models, the normal, overweight, and obese state in both 1 and 3-way connections were
simulated using increased amounts of adipose tissue and the adipose cell size remained
unchanged before and after the experiments over 24 hours. Although the capacity of HepG2
cells to metabolize xenobiotcs is limited, this immortalized human hepatocyte cell line is gen-
erally considered a suitable model of endogenous metabolism [35]. For this reason, although
freshly isolated hepatocytes would be more physiological and likely more predictive, we pre-
ferred to use the stable HepG2 cell line rather than add a new donor-dependent variable to the
system.
All our experiments were conducted with normal glucose medium concentration (5.5
mM), corresponding to a fasting state. Under the fasting state, adipose tissue provides free
fatty acid (FFA) and glycerol to the energy expenditure organs by hydrolysing triglycerides.
FFAs are also released when adipose tissue is in excess and transported through the vascular
system by albumin [36]. They are considered an important link between obesity, insulin resis-
tance, inflammation, development of Type 2 diabetes and associated cardiovascular disorders
[37]. In vivo, the elevated plasma FFA levels impair endothelial function [38] and are also asso-
ciated with an increase in vascular stress markers such as E-selectin [39]. In both the 1-, 2- and
3-way connections, triglycerides were released into the medium, but their levels were signifi-
cantly higher in the presence of increased adiposity (35%AT and 25%AT) in the 3-way circuit,
suggesting that the presence of other tissues stimulated their production in the adipose tissue
(Fig 2a). However, in our experiments, FFA levels did not correlate with adiposity in the 3-way
system, but were identical for 12%AT, 25%AT and 35%AT (Fig 2c). The fairly stable (com-
pared with 1- and 2-way circuits) FFA levels were associated with a significant increase in
human albumin concentration—this may be due to the fact that any excess FFA in the 3-way
35%AT and 25%AT conditions was bound to albumin, and hence not detectable in the media.
These results are coherent with in-vivo findings, as several studies on humans report a positive
correlation between elevated serum albumin levels, nutritional status and body mass index
(BMI), likely associated with albumin’s role as a carrier of FFAs [40,41].
Lactate is the major metabolite of glucose in adipose tissue and its amount is correlated
with the size and the number of adipocytes [42]. In 2-way and 3-way 35%AT circuits, medium
lactate levels were significantly increased. These results parallel several in vivo and in vitro
In-vitro model of central obesity
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studies which underline an altered lactate metabolism in obesity [43,44]. Interestingly, our
results also mirror those of Mårin et al., who found a higher glucose uptake in obese subjects
compared to lean subjects and consequently a significant increase of lactate release into the cir-
culation [45]. Adipose tissue is an important source of inflammatory cytokine production and
obesity is regarded as a state of chronic, low-grade inflammation [3]. One of the principal cyto-
kines, interleukin-6 (IL-6), is involved in inflammation and infection responses as well as in
the regulation of metabolic, regenerative, and neural processes. It has been observed that adi-
pocytes from obese individuals secrete IL-6, an activity which is correlated with adipocyte vol-
ume [46]. MCP-1 is a small inducible cytokine that belongs to the CC chemokine family which
recruits monocytes, memory T cells, and dendritic cells to the sites of inflammation produced
by either tissue injury or infection [47,48]. Shindu et al. showed that human obesity is associ-
ated with an elevated IL-6 expression in the adipose tissue, with increased tissue expression of
TNF-α, MCP-1, IP-10 and infiltration by macrophages as the underlying features of a chronic
low-grade inflammation [49]. They also found that the MCP-1 upregulation in obese adipose
tissue samples correlated with increased IL-6 and suggested that the latter induces subsequent
metabolic inflammation.
IL-6 concentrations increased significantly when HUVEC and hepatocytes were connected
to 35%AT or 25%AT, compared with the 1-way and 2-way controls and 3-way 12%AT. The
increased IL-6 levels were not due simply to the increased proportion of AT, but also a conse-
quence of the cross-talk between the 3 tissue types as verified by comparing the cytokine con-
centrations in the 3-way connections with those in the presence of 1- or 2-way 12%AT, 25%
AT and 35%AT (Fig 4a). In fact, the interaction analysis shows that the 3-way cross-talk has a
substantial upregulating effect (p<0.0001) on the expression of IL-6 in relation to adiposity.
In the case of MCP-1 expression, the interaction effect was not significant as we observed
an increase in MCP-1 with adiposity in both 1-, 2- and 3-way groups (Fig 4b). However, the
increase in the obese (35%AT) 3-way group was significant compared with all other 3-way
conditions (p<0.0183, 2-way ANOVA). Similarly, the MCP-1 levels in the 3-way 35%AT were
significantly higher than all other obese conditions (ie 1-way 35%AT and 2-way 35%AT, see
SI). These data suggest that, in our context, MCP-1 induction is closely linked to the amount
of adipose tissue and the degree of induction may be stimulated by IL-6, similar to Shindu
et al.’s findings in humans [42].
A marked dependency on adiposity was also observed for the endothelial specific inflam-
matory markers. In the 12%AT 3-way connection, medium E-selectin levels were very low and
remained stable over time, while high levels were released into the medium in 35%AT and
25%AT 3-way systems. Similar results were observed for vWF expression, the only difference
being the much higher levels of vWF fluorescence in the 3-way 25%AT with respect to 35%
AT, 12%AT and 1-way HUVEC controls. It is likely that the endothelial cell response is medi-
ated by the adipose and 3-way cross-talk related increase in IL-6 and MCP-1, as it is well
known that endothelial cells respond to these pro-inflammatory markers in-vitro [50–53].
Together, these observations indicate that an increasing amount of adipose tissue may cause
early endothelial damage and vascular stress, as already demonstrated in-vivo, in humans
[54,55].
In conclusion, the data show that an increase of adiposity in-vitro determines a pro-inflam-
matory state and results in endothelial stress as observed in vivo. The results also underline
that i) the simple superposition principle cannot merely be applied to predict tissue responses
in complex multi-organ models due to systemic cross-talk, and ii) the presence of all 3 tissues
in the system is crucial to obtain the integrated, synergic inflammatory responses observed.
The use of human hepatocytes and long term, chronic experiments which also consider
changes in adipose cell volume over time are certainly amongst the next steps to consider for
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improving the system to make it more physiologically relevant. Additionally, more extensive
metabolic and inflammatory profiling of the models would help contribute to a better under-
standing of the cross-talk between the tissues and strengthen their predictive potential.
This first example of an in-vitro model of central obesity using interconnected tissue mod-
els clearly demonstrates that it is possible to recapitulate the main features of adiposity related
systemic and cardiovascular stress typically observed in humans without resorting to animal
models. Engineered non-animal models, in which multiple tissue interactions can be studied
piecewise, may help unravel some of the mechanisms of obesity induced metabolic disorders
and could, in the future, aid in the design of novel therapeutic interventions. Our study dem-
onstrates the feasibility of this approach and paves the way for further investigations focusing
on chronic obesity, lipo-rich diets, hyperglycaemia, and patient-specific responses.
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